Minister for Patient Safety and Primary Care Maria Caulfield MP will be questioned in the final session of the inquiry into the future of general practice on Tuesday 12 July at 11.05am
You can find links to watch the session here, for more information on the inquiry here and the committee here.
Scope of the session
Key issues that have been raised in earlier evidence sessions are expected to be discussed, including the continuity of care for patients, the future of the GP partnership model, and regional variation in general practice.
The inquiry into the future of General Practice has taken evidence on the GP workforce, the recruitment and retention and non-GP staff, the GP partnership model, patient access, and the integration of primary and secondary care. It has also examined the impact of the NHS backlog on general practice.
Witnesses
Tuesday 12 July at 11.05am in Committee Room 6, Palace of Westminster
Maria Caulfield MP, minister for Patient Safety and Primary Care 
Matthew Style, director-general for NHS Policy and Performance, Department of Health and Social Care
Dr Nikki Kanani, medical director of Primary Care, NHS EnglandÂ
Dr Amanda Doyle, director of Primary Care, NHS England
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events relating to CSL Seqirus products should also be reported to Seqirus UK Limited on 01748 828816.
1. Seqirus Data on File, August 2023. SREF–17994. 2. Adjuvanted Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics. 3. Cell-based Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics.
Be the first to comment